• Login
    View Item 
    •   SOAR Home
    • Liberal Arts and Sciences
    • Chemistry
    • CHEM Faculty Scholarship
    • CHEM Faculty Publications
    • View Item
    •   SOAR Home
    • Liberal Arts and Sciences
    • Chemistry
    • CHEM Faculty Scholarship
    • CHEM Faculty Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Neutrophil elastase inhibitors

    Date
    2011-03-01
    Author
    Groutas, William C.
    Dou, Dengfeng
    Alliston, Kevin R.
    Metadata
    Show full item record
    Citation
    Expert opinion on therapeutic patents. 2011 Mar; 21(3): 339-54.
    Abstract
    INTRODUCTION: Chronic obstructive pulmonary disease (COPD) constitutes a worldwide health problem. There is currently an urgent and unmet need for the development of small molecule therapeutics capable of blocking and/or reversing the progression of the disorder. Recent studies have greatly illuminated our understanding of the multiple pathogenic processes associated with COPD. Of paramount importance is the key role played by proteases, oxidative stress, apoptosis and inflammation. Insights gained from these studies have made possible the exploration of new therapeutic approaches. AREAS COVERED: An overview of major developments in COPD research with emphasis on low-molecular mass neutrophil elastase inhibitors is described in this review. EXPERT OPINION: Great strides have been made toward our understanding of the biochemical and cellular events associated with COPD. However, our knowledge regarding the inter-relationships among the multiple pathogenic mechanisms and their mediators involved is still limited. The problem is further compounded by the unavailability of suitable validated biomarkers for assessing the efficacy of potential therapeutic interventions. The complexity of COPD suggests that effective therapeutic interventions may require the administration of more than one agent such as a human neutrophil elastase or MMP-12 inhibitor with an anti-inflammatory agent such as a PDE4 inhibitor or a dual function agent capable of disrupting the cycle of proteolysis, apoptosis, inflammation and oxidative stress.
    Description
    Click on the DOI link below to access the article (may not be free).
    URI
    http://dx.doi.org/10.1517/13543776.2011.551115
    http://hdl.handle.net/10057/4261
    Collections
    • CHEM Faculty Publications [394]

    SOAR is a service of Wichita State University Libraries
    Contact Us | Send Feedback
    Site statistics 
     

     

    Browse

    All of SOARCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeThis CollectionBy Issue DateAuthorsTitlesSubjectsType

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    SOAR is a service of Wichita State University Libraries
    Contact Us | Send Feedback
    Site statistics